Research Paper Volume 15, Issue 19 pp 10305—10329

The integrated single-cell analysis developed an immunogenic cell death signature to predict lung adenocarcinoma prognosis and immunotherapy


Figure 1. The flowchart of this investigation. To integrate multiple datasets to explore the role of ICD in the TME of LUAD, and to construct a signature to predict the prognosis and immunotherapy of LUAD patients.